PDL BioPharma, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 5.211 million compared to USD 7.458 million a year ago. Operating loss was USD 13.763 million compared to USD 9.257 million a year ago. Net loss was USD 49.971 million compared to USD 4.419 million a year ago. Basic loss per share was USD 0.43 compared to USD 0.04 a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.07 a year ago. For the half year, total revenue was USD 11.206 million compared to USD 14.154 million a year ago. Operating loss was USD 45.522 million compared to USD 17.473 million a year ago. Net loss was USD 81.694 million compared to net income of USD 2.261 million a year ago. Basic loss per share was USD 0.68 compared to basic earnings per share of USD 0.02 a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.13 a year ago.